The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The reported enterovirus A 71 (EVA71) vaccines and immunoglobin G (IgG) antibodies have no cross‐antiviral efficacy against other enterovirus A (EV‐A) which caused hand, foot and mouth disease (HFMD). Here we constructed an IgM antibody (20‐IgM) based on our previous discovery to address the resistance encountered by IgG‐based immunotherapy. Although binding to the same conserved neutralizing epitope...
Evidence suggests that the anti‐inflammatory nucleoside adenosine can shape immune responses by shifting the regulatory (Treg)/helper (Th17) T‐cell balance in favour of Treg. Since this observation is based on in vivo and in vitro studies mostly confined to murine models, we comprehensively analysed effects of adenosine on human T‐cells. Proliferation, phenotype and cytokine production of stimulated...
Allergic diseases are caused by dysregulated Th2 immune responses involving multiple effector cells including basophils. Short chain fatty acids (SCFAs), mainly acetate, propionate and butyrate, exert immunomodulatory functions via activation of its receptors GPR41 and GPR43, and inhibition of the histone deacetylases (HDACs) activity. In allergic diseases, SCFAs suppress the activity of mast cells,...